Travere Therapeutics, Inc.'s (NASDAQ:TVTX) Path To Profitability

Simply Wall StJan 11 21:16

Cantor Fitzgerald Initiates Travere Therapeutic(TVTX.US) With Buy Rating

Futu NewsJan 11 01:31 · Ratings

Cantor Fitzgerald Initiates Travere Therapeutics at Overweight

MT NewswiresJan 10 23:48

BofA Securities Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Announces Target Price $24

Futu NewsJan 6 19:31 · Ratings

Travere Therapeutics Insider Sold Shares Worth $258,278, According to a Recent SEC Filing

MT NewswiresDec 30, 2024 17:05

J.P. Morgan's Top Healthcare Stocks for 2025

Seeking AlphaDec 21, 2024 00:30